ARL6IP5 and breast carcinoma: In several cancers, such as skin cancer, pancreatic cancer, and breast cancer, the tumor suppressive role of ARL6IP5 was found to be mediated via its inhibitory effects on MAPK signaling pathway and JNK pathways [53–56].